Medicure Inc. (MPH.V)
CAD 0.9
(0.0%)
CAD 0.9
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.82 Million CAD | -45.33% |
| 2022 | -4 Million CAD | -58.73% |
| 2021 | -2.52 Million CAD | -98.98% |
| 2020 | -1.26 Million CAD | 89.31% |
| 2019 | -11.87 Million CAD | 50.8% |
| 2018 | -24.13 Million CAD | -358.88% |
| 2017 | -5.26 Million CAD | -108.69% |
| 2016 | 60.51 Million CAD | 8875.72% |
| 2015 | 674.19 Thousand CAD | -84.63% |
| 2014 | 4.38 Million CAD | 0.0% |
| 2012 | 4.65 Million CAD | 32.12% |
| 2011 | 3.52 Million CAD | -83.78% |
| 2010 | 21.71 Million CAD | -8.63% |
| 2009 | 23.76 Million CAD | 3.06% |
| 2008 | 23.06 Million CAD | 3.51% |
| 2007 | 22.28 Million CAD | 250.27% |
| 2006 | -14.82 Million CAD | 57.54% |
| 2005 | -34.92 Million CAD | -360.03% |
| 2004 | -7.59 Million CAD | 61.96% |
| 2003 | -19.95 Million CAD | -383.1% |
| 2002 | -4.13 Million CAD | 50.48% |
| 2001 | -8.34 Million CAD | -120.93% |
| 2000 | -3.77 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -5.59 Million CAD | 3.9% |
| 2024 Q2 | -5.44 Million CAD | 2.68% |
| 2023 Q4 | -5.82 Million CAD | -16.13% |
| 2023 Q2 | -4.75 Million CAD | -14.48% |
| 2023 FY | -5.82 Million CAD | -45.33% |
| 2023 Q3 | -5.01 Million CAD | -5.58% |
| 2023 Q1 | -4.15 Million CAD | -3.54% |
| 2022 Q3 | -3.54 Million CAD | 7.02% |
| 2022 Q4 | -4 Million CAD | -13.0% |
| 2022 FY | -4 Million CAD | -58.73% |
| 2022 Q1 | -1.71 Million CAD | 32.28% |
| 2022 Q2 | -3.81 Million CAD | -123.1% |
| 2021 Q3 | -2.06 Million CAD | -77.19% |
| 2021 Q1 | -1.48 Million CAD | -17.02% |
| 2021 Q4 | -2.52 Million CAD | -22.22% |
| 2021 FY | -2.52 Million CAD | -98.98% |
| 2021 Q2 | -1.16 Million CAD | 21.48% |
| 2020 Q2 | -10.25 Million CAD | 11.96% |
| 2020 FY | -1.26 Million CAD | 89.31% |
| 2020 Q3 | -10.92 Million CAD | -6.54% |
| 2020 Q1 | -11.64 Million CAD | 1.94% |
| 2020 Q4 | -1.26 Million CAD | 88.38% |
| 2019 FY | -11.87 Million CAD | 50.8% |
| 2019 Q2 | -45.18 Million CAD | -375.28% |
| 2019 Q3 | -35.25 Million CAD | 21.98% |
| 2019 Q1 | -9.5 Million CAD | 60.62% |
| 2019 Q4 | -11.87 Million CAD | 66.31% |
| 2018 Q1 | -14.39 Million CAD | -173.59% |
| 2018 FY | -24.13 Million CAD | -358.88% |
| 2018 Q4 | -24.13 Million CAD | -19.34% |
| 2018 Q3 | -20.22 Million CAD | -17.15% |
| 2018 Q2 | -17.26 Million CAD | -19.97% |
| 2017 FY | -5.26 Million CAD | -108.69% |
| 2017 Q4 | -5.26 Million CAD | -109.55% |
| 2017 Q3 | 55.09 Million CAD | -1.24% |
| 2017 Q2 | 55.79 Million CAD | 11.77% |
| 2017 Q1 | 49.91 Million CAD | -17.51% |
| 2016 FY | 60.51 Million CAD | 8875.72% |
| 2016 Q2 | -4.02 Million CAD | 6.35% |
| 2016 Q1 | -4.3 Million CAD | -737.94% |
| 2016 Q3 | -5.79 Million CAD | -43.95% |
| 2016 Q4 | 60.51 Million CAD | 1143.71% |
| 2015 Q4 | 674.19 Thousand CAD | 19.04% |
| 2015 Q1 | 3.63 Million CAD | 0.0% |
| 2015 Q3 | 566.38 Thousand CAD | 237.71% |
| 2015 FY | 674.19 Thousand CAD | -84.63% |
| 2015 Q2 | -411.27 Thousand CAD | -111.32% |
| 2014 FY | 4.38 Million CAD | 0.0% |
| 2014 Q1 | 4.78 Million CAD | -0.44% |
| 2014 Q2 | 4.61 Million CAD | -3.61% |
| 2014 Q3 | 4.35 Million CAD | -5.5% |
| 2013 Q1 | 4.68 Million CAD | -6.65% |
| 2013 Q2 | 4.65 Million CAD | -0.72% |
| 2013 Q3 | 4.79 Million CAD | 2.91% |
| 2013 Q4 | 4.8 Million CAD | 0.34% |
| 2012 Q2 | 3.52 Million CAD | 12.62% |
| 2012 FY | 4.65 Million CAD | 32.12% |
| 2012 Q4 | 5.02 Million CAD | 4.73% |
| 2012 Q3 | 4.79 Million CAD | 36.12% |
| 2012 Q1 | 3.12 Million CAD | 53.56% |
| 2011 FY | 3.52 Million CAD | -83.78% |
| 2011 Q4 | 2.03 Million CAD | -51.92% |
| 2011 Q3 | 4.23 Million CAD | -80.49% |
| 2011 Q2 | 21.71 Million CAD | -0.96% |
| 2011 Q1 | 21.92 Million CAD | -6.5% |
| 2010 Q1 | 23.91 Million CAD | 0.98% |
| 2010 Q2 | 23.76 Million CAD | -0.6% |
| 2010 Q3 | 24.35 Million CAD | 2.47% |
| 2010 Q4 | 23.45 Million CAD | -3.7% |
| 2010 FY | 21.71 Million CAD | -8.63% |
| 2009 Q1 | 25.14 Million CAD | 8.01% |
| 2009 Q3 | 24.23 Million CAD | 5.07% |
| 2009 Q2 | 23.06 Million CAD | -8.29% |
| 2009 Q4 | 23.68 Million CAD | -2.27% |
| 2009 FY | 23.76 Million CAD | 3.06% |
| 2008 Q4 | 23.28 Million CAD | -22.05% |
| 2008 Q3 | 29.87 Million CAD | 34.07% |
| 2008 Q2 | 22.28 Million CAD | 36.19% |
| 2008 Q1 | 16.36 Million CAD | 467.68% |
| 2008 FY | 23.06 Million CAD | 3.51% |
| 2007 Q3 | -3.88 Million CAD | 73.79% |
| 2007 Q1 | -24.89 Million CAD | -570.28% |
| 2007 FY | 22.28 Million CAD | 250.27% |
| 2007 Q4 | -4.44 Million CAD | -14.5% |
| 2007 Q2 | -14.82 Million CAD | 40.43% |
| 2006 Q1 | -12.17 Million CAD | -239.42% |
| 2006 Q4 | -3.71 Million CAD | 60.11% |
| 2006 Q2 | -34.92 Million CAD | -186.92% |
| 2006 FY | -14.82 Million CAD | 57.54% |
| 2006 Q3 | -9.31 Million CAD | 73.34% |
| 2005 FY | -34.92 Million CAD | -360.03% |
| 2005 Q3 | -7.57 Million CAD | 0.23% |
| 2005 Q1 | -11.76 Million CAD | 17.79% |
| 2005 Q2 | -7.59 Million CAD | 35.46% |
| 2005 Q4 | -3.58 Million CAD | 52.65% |
| 2004 Q3 | -16.89 Million CAD | 15.31% |
| 2004 Q2 | -19.95 Million CAD | 8.72% |
| 2004 FY | -7.59 Million CAD | 61.96% |
| 2004 Q1 | -21.85 Million CAD | -110.47% |
| 2004 Q4 | -14.3 Million CAD | 15.34% |
| 2003 Q2 | -4.13 Million CAD | 20.36% |
| 2003 Q1 | -5.18 Million CAD | 8.57% |
| 2003 FY | -19.95 Million CAD | -383.1% |
| 2003 Q3 | -10.26 Million CAD | -148.51% |
| 2003 Q4 | -10.38 Million CAD | -1.18% |
| 2002 FY | -4.13 Million CAD | 50.48% |
| 2002 Q4 | -5.67 Million CAD | 19.03% |
| 2002 Q3 | -7 Million CAD | 0.0% |
| 2001 FY | -8.34 Million CAD | -120.93% |
| 2000 FY | -3.77 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 4.89 Million CAD | 219.034% |
| CanadaBis Capital Inc. | 4.08 Million CAD | 242.626% |
| Decibel Cannabis Company Inc. | 37.48 Million CAD | 115.54% |
| Delivra Health Brands Inc. | -2.17 Million CAD | -168.063% |
| Entourage Health Corp. | 150.32 Million CAD | 103.875% |
| Lifeist Wellness Inc. | -188.12 Thousand CAD | -2996.28% |
| Cannara Biotech Inc. | 41.51 Million CAD | 114.032% |
| PharmaCielo Ltd. | 18.24 Million CAD | 131.924% |
| Rubicon Organics Inc. | 475.37 Thousand CAD | 1325.356% |
| BioSyent Inc. | -3.68 Million CAD | -58.075% |
| Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | 15463.313% |